Skip to main content
. 2016 Sep 1;10(9):EC05–EC09. doi: 10.7860/JCDR/2016/20475.8539

[Table/Fig-2]:

Clinicopathological features of triple negative breast carcinomas.

Parameters(N=number of cases) Percentage (%)
Age(N=52) 46±12 years
Size(N=33) 4.3±2.56cm
Staging(N=47)
  I
II
III
IV

9
38
38
15
WHO subtype(N=52)
Invasive ductal carcinoma
Other subtypes

96
4
Histologic grading(N=49)
Grade II
Grade III

43
57
Tumour borders (N=45)
Pushing
Pushing and infiltrative
Infiltrative

38
31
31
Tumour infiltrating lymphocytes(N=52)
Absent
Mild
Moderate
Marked

2
54
33
11
Shape of cells(N=52)
Polygonal
Spindle

98
2
Type of chromatin(N=52)
Hyperchromatic
Vesicular
Hyperchromatic and vesicular

37
28
35
Nucleoli(N=52)
Inconspicuous
Present, but not prominent
Prominent

8
35
57
Amount of cytoplasm(N=52)
Moderate
Abundant

87
13
Nucleo-cytoplasmic ratio(N=52)
Low
High

2
98
Amount of intratumoural stroma(N=52)
Scant
Mild
Moderate
Abundant

44
25
27
4
Necrosis and central acellular sclerosis (N=52)
Necrosis
Absent
Present
Central geographic necrosis(N=52)
Absent
Present


96
4
98
Central acellular sclerosis without necrosis (N=52)
Absent
Present
2
88
12
Squamous metaplasia(N=52)
Absent
Present

94
6
Other Metaplasia(N=1) 2
Ductal carcinoma in situ(N=52)
Absent
Present

67
33
Lymphovascular invasion(N=52)
Absent
Present

31
69
Ishikawa subtypes
Type A(Atypical medullary carcinoma)
Type B (Carcinoma with central acellular zone)
Type C (other invasive ductal carcinoma)
Type D (Special types)

15
14
67
4